[ U.S. DEPARTMENT OF DEFENSE - Kidney Cancer Research Program Translational Research Partnership Award | Research Office ]
Event details
| Date | 05.09.2018 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Kidney Cancer Research Program (KCRP) for 2018. The KCRP Translational Research Partnership Award mechanism supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in kidney cancer toward clinical applications. The ultimate goal of translational research is to move a concept or observation forward into clinical application; However, there should also be an intellectual synergistic partnership between the clinic and the laboratory. Results should be relevant to active duty Service members, Veterans, other military beneficiaries, and the American public.
Preliminary data to support the feasibility of the research hypothesis and research approaches are required; however, these data do not necessarily need to be derived from studies of kidney cancer.
Funding: Maximum USD $ 600’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or higher are eligible to submit applications. One partner in the collaboration must be a research scientist and the other must be a clinician. Multi-institutional partnerships are encouraged. At least one member of the partnership must have experience either in kidney cancer research or kidney cancer patient care, but inclusion of experts from outside the kidney cancer field is encouraged.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a letter of intent, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 05 September 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 26 September 2018, 11:59 p.m. EST (05:59 27 Sep, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-KCRP-TRPA
Further information
Preliminary data to support the feasibility of the research hypothesis and research approaches are required; however, these data do not necessarily need to be derived from studies of kidney cancer.
Funding: Maximum USD $ 600’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or higher are eligible to submit applications. One partner in the collaboration must be a research scientist and the other must be a clinician. Multi-institutional partnerships are encouraged. At least one member of the partnership must have experience either in kidney cancer research or kidney cancer patient care, but inclusion of experts from outside the kidney cancer field is encouraged.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a letter of intent, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 05 September 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 26 September 2018, 11:59 p.m. EST (05:59 27 Sep, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-KCRP-TRPA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-18-KCRP-TRPA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Practical information
- General public
- Free